Capecitabine 500 mg F.C. Tablets (Kapetral®)
【Registration Number】027229
【Active Ingredient】Capecitabine 500 mg
【Indication】
Capecitabine 500 mg F.C. Tablets (Kapetral®) is a nucleoside metabolic inhibitor with antineoplastic activity indicated for:
•Adjuvant Colon Cancer
-Patients with Dukes'C colon cancer.
•Metastatic Colorectal Cancer
-First-line as monotherapy when treatment with fluoropyrimidine therapy alone is preferred.
•Metastatic Breast Cancer
-In combination with docetaxel after failure of prior anthracyclinecontaining therapy.
-As monotherapy in patients resistant to both paclitaxel and an anthracycline-containing regimen.
【Manufacturer】Remedica Ltd.
【Manufacturer Address】Aharnon Street, Limassol Industrial Estate, Limassol, 3056, Cyprus.
【Category】Prescription Drug